Bills/S. 3797

Prohibiting Tianeptine and Other Dangerous Products Act of 2026

Prohibiting Tianeptine and Other Dangerous Products Act of 2026

In CommitteeHealthcareSenateSenate Bill · 119th Congress
Bill Progress · Senate
Introduced
Committee
Passed House
Passed Senate
Passed Both
Signed

Plain Language Summary

# Prohibiting Tianeptine and Other Dangerous Products Act of 2026 - Summary **What It Does:** This bill would prohibit the sale and distribution of tianeptine, a drug that is not currently approved by the FDA but is being sold in the U.S. under names like "Za Za Red" and "Tianna." Tianeptine is a prescription antidepressant in other countries but is marketed here as a dietary supplement or nootropic (cognitive enhancer). The bill aims to add tianeptine to the list of controlled substances, making it illegal to manufacture, possess, or sell without authorization. **Who It Affects:** The legislation would impact consumers who currently purchase tianeptine products, retailers and online sellers offering these products, and manufacturers distributing them. The bill also relates to concerns raised by public health officials, as tianeptine has potential for abuse and dependence, with some users reporting withdrawal symptoms similar to opioids. **Current Status:** As of now, the bill (S.

3797) is in committee and has not yet been voted on by the full Senate. It was introduced by Senator Richard J. Durbin (D-Illinois) during the 119th Congress. No further action has been reported.

Advertisement

Latest Action

February 5, 2026

Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S512)

Sponsor

1 cosponsor

Key Dates

Introduced
February 5, 2026
Last Updated
February 5, 2026
Read Full Text on Congress.gov →
Advertisement